Oculis Operations Sàrl

Suisse


Commandez votre montre hebdomadaire Oculis Operations Sàrl
Quantité totale PI 35
Rang # Quantité totale PI 41 479
Note d'activité PI 2,6/5.0    47
Rang # Activité PI 15 532
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

21 4
2 1
4 4
0
 
Dernier brevet 2025 - Synthesis of small molecule agon...
Premier brevet 2017 - Preparation of solid cyclodextri...
Dernière marque 2021 - OCULIS
Première marque 2019 - OCULIS

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 Invention Synthesis of small molecule agonists of neuroptrophin. The disclosure concerns a process for syn...
Invention Preparation of solid cyclodextrin complexes for ophthalmic active pharmaceutical ingredient deliv...
2024 Invention Method of treating diabetic macular edema. The present disclosure relates to a method of treating...
Invention Method of treating diabetic macular edema. The present disclosure relates to a method of treatin...
Invention Treatment of ocular inflammation following ocular surgery. The present disclosure relates to a me...
Invention Treatment of ocular inflammation with ophthalmic compositions. The present disclosure relates to ...
Invention Ph stabilized ophthalmic dexamethasone compositions. The present disclosure relates to a method f...
Invention Ph stabilized ophthalmic compositions. The present disclosure relates to a method for stabilizing...
Invention Stabilized ophthalmic dexamethasone compositions. The present disclosure relates to a method for ...
Invention Treatment of diabetic retinopathy with ophthalmic compositions. The present disclosure relates to...
Invention Multidose ophthalmic compositions. The present invention relates to aqueous cyclodextrin composi...
2023 Invention Synthesis of small molecule agonists of neuroptrophin. 11616161233 is chosen from propyl, 1-methy...
Invention Ph stabilized topical ophthlamic compositions. The present disclosure relates to a method for st...
Invention Treatment of ocular inflammation. The present disclosure relates to a method for stabilizing the ...
Invention Ocular inflammation treatment with stabilized dexamethasone. The present disclosure relates to a...
Invention Treatment of diabetic retinopathy. The present disclosure relates to a method for stabilizing the...
Invention Stabilized dexamethasone compositions. The present disclosure relates to a method for stabilizing...
Invention Eye drop microsuspensions of mtor inhibitors. The present invention relates to an aqueous eye dro...
2021 P/S Substances et préparations médicales et pharmaceutiques, nommément préparations pharmaceutiques p...
P/S Medical and pharmaceutical preparations and substances; liquid solutions for the treatment of op...
P/S Pharmaceutical preparations of solid cyclodextrin complexes for topical ophthalmic drug delivery
P/S Pharmaceutical preparations of solid cyclodextrin complexes for topical ophthalmic drug delivery.
P/S Topical drug formulation for ophthalmic use
P/S Topical drug formulation for ophthalmic use.
2020 Invention Diabetic retinopathy treatment with stabilized dexamethasone. A method is described of stabilizin...
2019 P/S Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical prep...